Clinical Trial Update: Angiotensin Receptor Blockers in Aortic Stenosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating angiotensin receptor blockers for aortic stenosis is currently recruiting. No results are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Drugs mentioned

• Angiotensin receptor blockers (ARB) (angiotensin II receptor blocker)

Snippet

Sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval | Conditions: Aortic Stenosis, Aortic Valve Stenosis | Phase 4 | Status: RECRUITING